
Big Pharma
Will Chinese Drugs Be Cuttoff? US BioTech at Crossroads
In the last several months, the Trump administration has been drafting an executive order about Chinese pharmaceuticals that would seriously change the landscape for the American biotech/pharmaceutical sector. The executive